SERVICE DE NEUROLOGIE Pathologies du mouvement Centre expert Parkinson (région Ile-de-France) Hôpital Henri Mondor

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Parkinson disease

Running trials

• Not yet recruiting

  Trial Evaluating the Efficacy of Pimavanserin, a Selective Serotonin 5-HydroxyTryptamine-2A (5HT2A) Inverse Agonist, to Treat Impulse Control Disorders in Parkinson's Disease.

  NCT06754553· University Hospital, Strasbourg, France· Source

  Contact: PHILIPPE REMY, MD PhD

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Parkinson disease1 recruiting